BioSpace News Archive

Center for Inherited Blood Disorders Administers Country’s First Gene Therapy Infusion to Treat Hemophilia A

Today, the Center for Inherited Blood Disorders (CIBD) announced the successful administration of the first gene therapy infusion in the country to treat hemophilia A outside of the clinical trial setting.

January 11, 2024
·
3 min read
Genetown

Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference

Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference.

January 11, 2024
·
1 min read
Business

United Digestive Implements Innovative Education Program from Boston Scientific

United Digestive has introduced a personalized education program powered by Boston Scientific.

January 11, 2024
·
2 min read
Business

DNAnexus and Intelliseq Combine Efforts to Add Automated Genomic Variant Interpretation and Clinical Reporting Capabilities to Precision Health Data Cloud

DNAnexus, Inc. today announced a partnership to simplify and accelerate variant interpretation and clinical reporting.

January 11, 2024
·
3 min read
Business

Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Pr. Xavier Declèves

VECT-HORUS today announced the appointment Pr. Xavier Declèves to its scientific advisory board (SAB).

January 11, 2024
·
2 min read
DecisionRx Announces $100 Million Credit Facility with Carlyle

DecisionRx, Inc. today announced that it has entered into a $100 million credit facility with global investment firm Carlyle.

January 11, 2024
·
4 min read
BioCapital

U.S. Army Reserve Awards SAIC $156 Million Contract for IT Service Management

Science Applications International Corp. has been awarded a $156 million contract to provide system support to the U.S. Army Reserve Command through their United States Army Reserve Command Information Technology Support Services contract.

January 11, 2024
·
4 min read
Deals

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced it will regain global commercialization rights to FAMPYRA ® (fampridine) following a decision by Biogen to terminate the license and collaboration agreement between the companies, effective January 1, 2025.

January 11, 2024
·
6 min read
Business

Xcell Biosciences Announces Collaboration with ElevateBio to Advance Technology Development for Cell and Gene Therapies

Xcell Biosciences, Inc. today announced a collaboration with ElevateBio, LLC (ElevateBio), through which the companies aim to explore novel approaches to improving therapeutic potency of cell and gene therapies.

January 11, 2024
·
3 min read
Business

ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer

ELIQUENT Life Sciences today announced the appointment of Steve Purtell as its new chief financial officer (CFO).

January 11, 2024
·
3 min read